ReEmerge, Inc. Exits Stealth with Oversubscribed $37M Series A to Challenge the Limitations of Chronic Cognitive Impairment Caused by Brain Injuries

Summary

ReEmerge, Inc. announced an oversubscribed $37M Series A funding round to advance its Cognitive Network Restoration Therapy (CNRT) technology for treating chronic cognitive impairment from brain injuries. The company exited stealth mode with the capital to support development of its technology targeting executive function recovery.